Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inaji

Showing results (251-260 of 298) with videos related to

Pageof 30
Sort By:
Oncology|February 5, 2003
Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancerTomohiko Aihara, Yuichi Takatsuka, Kuniaki Itoh, et al.
Brain Research|November 22, 2005
Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned ratsMotoki Inaji, Takashi Okauchi, Kiyoshi Ando, et al.
Cancers|March 25, 2022
Correlation of Intraoperative 5-ALA-Induced Fluorescence Intensity and Preoperative <sup>11</sup>C-Methionine PET Uptake in Glioma SurgeryKazuhide Shimizu, Kaoru Tamura, Shoko Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 13, 2006
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]Hideo Inaji, Katsuji Sakai, Takahiro Oka, et al.
Japanese Journal of Clinical Oncology|January 30, 2010
Clinical utility of the 70-gene MammaPrint profile in a Japanese populationMakoto Ishitobi, Teodora E Goranova, Yoshifumi Komoike, et al.
Breast Cancer (Tokyo, Japan)|March 14, 2013
Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTRMakoto Ishitobi, Yasuhiro Okumura, Reiki Nishimura, et al.
Breast Cancer (Tokyo, Japan)|April 18, 2022
Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trialHitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, et al.
Journal of Proteome Research|June 22, 2012
Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samplesSatoshi Muraoka, Hideaki Kume, Shio Watanabe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 3, 1998
[Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer]H Koyama, I Adachi, T Tajima, et al.
Journal of Neuro-Oncology|April 1, 2024
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of <sup>11</sup>C-methionine in IDH-mutant astrocytomaToshihiro Yamamura, Kaoru Tamura, Daisuke Kobayashi, et al.
Pageof 30

Showing results (251-260 of 298) with videos related to

Sort By:
Pageof 30
Oncology|February 5, 2003
Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancerTomohiko Aihara, Yuichi Takatsuka, Kuniaki Itoh, et al.
Brain Research|November 22, 2005
Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned ratsMotoki Inaji, Takashi Okauchi, Kiyoshi Ando, et al.
Cancers|March 25, 2022
Correlation of Intraoperative 5-ALA-Induced Fluorescence Intensity and Preoperative <sup>11</sup>C-Methionine PET Uptake in Glioma SurgeryKazuhide Shimizu, Kaoru Tamura, Shoko Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 13, 2006
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]Hideo Inaji, Katsuji Sakai, Takahiro Oka, et al.
Japanese Journal of Clinical Oncology|January 30, 2010
Clinical utility of the 70-gene MammaPrint profile in a Japanese populationMakoto Ishitobi, Teodora E Goranova, Yoshifumi Komoike, et al.
Breast Cancer (Tokyo, Japan)|March 14, 2013
Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTRMakoto Ishitobi, Yasuhiro Okumura, Reiki Nishimura, et al.
Breast Cancer (Tokyo, Japan)|April 18, 2022
Validation of a nuclear grading system for resected stage I-IIIA, high-risk, node-negative invasive breast carcinoma in the N·SAS-BC 01 trialHitoshi Tsuda, Masafumi Kurosumi, Futoshi Akiyama, et al.
Journal of Proteome Research|June 22, 2012
Strategy for SRM-based verification of biomarker candidates discovered by iTRAQ method in limited breast cancer tissue samplesSatoshi Muraoka, Hideaki Kume, Shio Watanabe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 3, 1998
[Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer]H Koyama, I Adachi, T Tajima, et al.
Journal of Neuro-Oncology|April 1, 2024
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of <sup>11</sup>C-methionine in IDH-mutant astrocytomaToshihiro Yamamura, Kaoru Tamura, Daisuke Kobayashi, et al.
Pageof 30